Climb Bio (CLYM) EPS (Basic) (2020 - 2026)
Climb Bio's (CLYM) quarterly EPS (Basic) came in at -$0.68 in Q1 2026, down 114.2% YoY from $4.75 in Q1 2025, and down 56.82% on a QoQ basis from -$0.43 in Q4 2025.
Powered by 
Analysis
Climb Bio (CLYM) EPS (Basic) (2020 - 2026) Analysis & Trends
Climb Bio (CLYM) has 7 years of EPS (Basic) data on file, last reported at -$0.68 in Q1 2026.
- Quarterly EPS (Basic) fell 114.2% year-over-year to -$0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.44 (changed 0.29% YoY) and the FY2025 annual result came in at -$1.05, up 50.55% from the prior year.
- EPS (Basic) eased to -$0.68 in Q1 2026, from -$0.43 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.1 in Q1 2024 to a low of -$1.9 in Q2 2024.
- A 5-year average of -$0.48 and a median of -$0.32 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) plunged 550.93% — and 2025, when it soared 93.35%.
- Tracing CLYM's EPS (Basic) over 5 years: stood at -$0.3 in 2022, then slumped by 209.36% to -$0.91 in 2023, then jumped by 80.34% to -$0.18 in 2024, then slumped by 140.01% to -$0.43 in 2025, then tumbled by 56.82% to -$0.68 in 2026.
- The last three EPS (Basic) figures came in at -$0.68 (Q1 2026), -$0.43 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Climb Bio | 1.20 Bn | 1.20 Bn | - | -0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.31 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -1.81 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -0.21 |
| Mar 31, 2023 | -0.85 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.56 |
| Mar 31, 2022 | -0.50 |
| Dec 31, 2021 | -0.86 |
| Sep 30, 2021 | -0.70 |